Nephrocare Health Services P/E Ratio
Current P/E Ratio
88.46
High Valuation
Very High - High growth expectations or significantly overvalued
Nephrocare Health Services (NEPHROPLUS) P/E ratio is 88.46 (High), EPS (TTM) ₹8.48, current price ₹671.95 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see NEPHROPLUS share price.
Current Valuation Metrics
P/E Ratio
88.46
Current Price
₹671.95
EPS (TTM)
₹8.48
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
112.22
Sector Median
42.3
Sector Rank
#11 of 57
Sector Percentile
19.3%
Earnings Breakdown (TTM)
TTM EPS
₹18.06
Mar 2026
₹3.03
Sept 2025
₹-1.12
NEPHROPLUS P/E Ratio — Valuation Signal & Historical Context
Nephrocare Health Services P/E 88.46 — signal: Overvalued. See Nephrocare Health Services P/B valuation to compare market price against book value per share.
- Stock appears overvalued with PE of 88.46, suggesting caution for new investments
- Trading at discount to sector average PE of 112.22
NEPHROPLUS vs Healthcare Services Peers — P/E Ratio Comparison
Nephrocare Health Services P/E 88.46 vs Healthcare Services average 112.22, median 42.3 — range 8.88–3151.25.
Sector Average
112.22
Sector Median
42.3
Lowest P/E
8.88
Highest P/E
3151.25
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.88 | ₹171 | Low |
| Shanmuga Hospital | SHANMUGA | 11.52 | ₹47 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.13 | ₹19 | Low |
| Abate AS Industries | ABATEAS | 12.81 | ₹158 | Low |
| Deccan Health Care | DECCAN | 13.27 | ₹33 | Low |
| 3B BlackBio DX | 3BBLACKBIO | 16.64 | ₹1,007 | Moderate |
| Sangani Hospitals | SANGANI | 16.86 | ₹62 | Moderate |
| Invicta Diagnostic | INVICTA | 17.27 | ₹87 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 17.27 | ₹1,764 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 19.22 | ₹3,485 | Moderate |